Vicarious Surgical Inc
NYSE:RBOT
Vicarious Surgical Inc
Vicarious Surgical, Inc. engages in advancing the field of surgical robotics. The company is headquartered in Waltham, Massachusetts. The company went IPO on 2020-09-04. The firm is focused on developing a technology for the surgical procedures, improving patient outcomes and healthcare. The Company’s surgical technology combines human-like surgical robots and virtual reality to transport surgeons inside the patient for minimally invasive surgery (MIS). The company is a combination of advanced miniaturized robotics, computer science and three-dimensional (3D) visualization to build a single-incision surgical robot, called the Vicarious System. The vicarious system is designed to provide visualization with a stereoscopic camera that rotates in three degrees of freedom (yaw, pitch, and roll) to provide the surgeon with stereoscopic imaging of virtually every surface in the abdomen. The vicarious system contains approximately 28 sensors per instrument arm, which allows the system to provide real-time feedback to the surgeon on force, motion and other data that are intended to develop surgical procedures.
Vicarious Surgical, Inc. engages in advancing the field of surgical robotics. The company is headquartered in Waltham, Massachusetts. The company went IPO on 2020-09-04. The firm is focused on developing a technology for the surgical procedures, improving patient outcomes and healthcare. The Company’s surgical technology combines human-like surgical robots and virtual reality to transport surgeons inside the patient for minimally invasive surgery (MIS). The company is a combination of advanced miniaturized robotics, computer science and three-dimensional (3D) visualization to build a single-incision surgical robot, called the Vicarious System. The vicarious system is designed to provide visualization with a stereoscopic camera that rotates in three degrees of freedom (yaw, pitch, and roll) to provide the surgeon with stereoscopic imaging of virtually every surface in the abdomen. The vicarious system contains approximately 28 sensors per instrument arm, which allows the system to provide real-time feedback to the surgeon on force, motion and other data that are intended to develop surgical procedures.
Cost Reduction: Vicarious Surgical cut operating expenses by 35% year-on-year and implemented headcount reductions to extend its cash runway.
Design Freeze Focus: The company's top priority remains achieving ‘design freeze’ for its surgical robot by end of 2026, despite some anticipated disruptions from outsourcing.
Outsourcing Initiative: Engaged PA Consulting to identify and manage outsourcing opportunities aimed at improving capital efficiency without derailing timeline.
Cash Burn: Q3 cash burn was about $10.5 million; management reiterated a full-year 2025 cash burn expectation of about $50 million, with plans to materially reduce burn in 2026.
Balance Sheet: Raised $5.9 million in gross proceeds from an October direct offering, boosting post-quarter liquidity.
Clinical Progress: Internal surgeon testing and OR labs showed significant improvements in system stability and procedural speed, notably reducing procedure times from 40 to 14 minutes in key tests.
Communication Efforts: Announced a new initiative to regularly update stakeholders via LinkedIn and the IR website, aiming for greater transparency.
